Insider · CIK 0001801061
Todd Franklin Watanabe
Files at ARQT (Arcutis Biotherapeutics, Inc.). First filing Nov 5, 2024, latest May 5, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ARQT: Arcutis Biotherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | Arcutis Biotherapeutics, Inc. | $174k 11,448 shares | -1% | +83% from low-12% from high | |
| 18Weak | Arcutis Biotherapeutics, Inc. | $64k 3,671 shares | -0% | +108% from low0% from high | |
| 10Weak | Arcutis Biotherapeutics, Inc. | $21k 1,200 shares | -0% | - | |
| 25Weak | Arcutis Biotherapeutics, Inc. | $327k 25,015 shares | -3% | - | |
| 23Weak | Arcutis Biotherapeutics, Inc. | $245k 19,301 shares | -2% | - | |
| 23Weak | Arcutis Biotherapeutics, Inc. | $228k 15,000 shares | -2% | - | |
| 18Weak | Arcutis Biotherapeutics, Inc. | $21k 6,038 shares | +1% | - | |
| 20Weak | Arcutis Biotherapeutics, Inc. | $120k 13,871 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | ARQT Arcutis Biotherapeutics, Inc. | GGift Common Stock | -997 | $0.00 | $0 | 914,113 | Jun 12, 2025 |
| Jun 10, 2025 | ARQT Arcutis Biotherapeutics, Inc. | GGift Common Stockindirect: By Trust | +997 | $0.00 | $0 | 25,410 | Jun 12, 2025 |
| Jun 10, 2025 | ARQT Arcutis Biotherapeutics, Inc. | GGift Common Stock | -997 | $0.00 | $0 | 913,116 | Jun 12, 2025 |
| Jun 10, 2025 | ARQT Arcutis Biotherapeutics, Inc. | GGift Common Stockindirect: By Trust | +997 | $0.00 | $0 | 25,410 | Jun 12, 2025 |
| May 2, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -11,448 | $15.19 | $174k | 913,795 | May 5, 2025 |
| Mar 24, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,500 | $17.52 | $26k | 927,414 | Mar 26, 2025 |
| Mar 25, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -2,171 | $17.56 | $38k | 925,243 | Mar 26, 2025 |
| Mar 17, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,200 | $17.61 | $21k | 928,914 | Mar 20, 2025 |
| Feb 28, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Common Stock10b5-1 | +151,000 | $0.00 | $0 | 955,129 | Mar 4, 2025 |
| Mar 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -20,880 | $13.03 | $272k | 934,249 | Mar 4, 2025 |
| Mar 4, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,135 | $13.28 | $55k | 930,114 | Mar 4, 2025 |
| Feb 28, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative10b5-1 | +396,000 | $0.00 | $0 | 396,000 | Mar 4, 2025 |
| Feb 3, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -19,301 | $12.70 | $245k | 804,129 | Feb 4, 2025 |
| Dec 20, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -15,000 | $15.17 | $228k | 823,430 | Dec 23, 2024 |
| May 31, 2024 | ARQT Arcutis Biotherapeutics, Inc. | POpen-market purchase Common Stock | +4,000 | $1.69 | $6,768 | 836,392 | Dec 3, 2024 |
| Nov 30, 2024 | ARQT Arcutis Biotherapeutics, Inc. | POpen-market purchase Common Stock | +2,038 | $7.11 | $14k | 838,430 | Dec 3, 2024 |
| Nov 4, 2024 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -13,871 | $8.68 | $120k | 832,392 | Nov 5, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.